This article is more than 5 years old. Information may no longer be current.
Microbiome testing service receives $1.4 million in funding
Click Here to Manage Email Alerts
Thryve, a monthly microbiome testing and personalized probiotics subscription service founded in 2016, announced it received $1.4 million in funding from several investment firms.
The company said the funds will allow them to increase new research, develop their technology and reach new customers.
“Thryve’s goal is to accentuate the importance of gut health and provide consumers with an easy, accurate and affordable way to learn about and improve their own gut health,” Richard Lin, founder and CEO of Thryve, said in a press release. “The financial support from this fundraising will help us continue our mission to empower others to take charge of their gut health. Thryve exists to bring awareness to everyone’s personal gut health status and use the power of technology and science to help generate a positive impact.”
As part of Thryve’s service, they send out monthly testing kits so subscribers can see exactly how the makeup of their gut microbiome is affecting their health. The company then arranges a personalized shipment of probiotics to fit each person’s needs. Subscribers also receive a monthly report to help them track their progress, according to the press release.
The company uses proprietary software to analyze more than 35,000 research articles on microbiome health, and they have gathered information on more than 4,000 microbes, including their health benefits, side effects, functions and more, the company told Healio Gastroenterology and Liver Disease in an email. They have also linked these microbes to more than 1,000 food ingredients and hundreds of supplements, the company said.
Thryve said this personalized approach leads to both improvement in subjective symptoms and microbiome data.
“Customers who have gone on our program not only improved their symptoms, but also increased beneficial bacteria, microbiome diversity and lowered pathogenic bacteria,” the company said in an email. – by Alex Young
Disclosures: Lin is employed by Thryve.